Indices dipped after Johnson & Johnson (JNJ.US) release results of coronavirus vaccine trials. The company said that its one-shot vaccine is 66% effective overall in moderate to severe cases, according to findings of the global clinical trial. Shots were generally well tolerated among trial participants. This is a slightly disappointing result given that some available vaccines have prevented virus infections in over 90% of cases. However, the vaccine is said to be 85% effective in preventing severe cases. Company plans to file for the emergency use approval in the United States in early February.
DE30 dropped around 1% following lacklustre results of Johnson&Johnson coronavirus vaccine trials. Source: xStation5
Daily Summary: US dollar reaches new highs, Wall Street, gold and bitcoin fall (23.09.2026)
US Open: Nasdaq drops from the all-time high (23.09.2026)
US PMIs skyrocket to a 5-year high
Market wrap: European indices under pressure from a stronger dollar ๐ฉ Quantum stocks Gain, IONQ jumps 12%